Budd Lake, NJ, United States of America

Aleksandr Kaplunovsky

This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Anthrogenesis Corporation, Antrhogenesis Corporation. Active years: 2013-2016.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aleksandr Kaplunovsky: Innovating for Celularity Inc.

Introduction

Aleksandr Kaplunovsky is an innovative professional based in the United States, currently contributing his skills and expertise at Celularity Inc. Although he does not hold any patents, his work in the field of biotechnology plays a significant role in advancing research and development.

Latest Patents

As of now, Aleksandr Kaplunovsky does not have any patents registered under his name. However, his contributions to Celularity Inc. may potentially lead to innovative developments that could result in patent applications in the future.

Career Highlights

Kaplunovsky has established himself as a key player at Celularity Inc., a company known for its focus on cell-based therapies and innovations in regenerative medicine. His dedication and professional skills contribute meaningfully to the company's ongoing projects.

Collaborations

Working alongside talented individuals such as Mohit B Bhatia, Aleksandr fosters a collaborative environment at Celularity Inc. This teamwork enhances the research capabilities within the company, pushing the boundaries of biotechnology and therapeutic solutions.

Conclusion

Aleksandr Kaplunovsky is an integral part of Celularity Inc., where he diligently works toward advancements in biotechnology. Although he currently does not hold any patents, his collaborative efforts suggest a bright future in innovation and potential contributions to the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…